Your search for tofacitinib returned 3 results

Part of the challenge of effective management of noninfectious uveitis is that it is not really a single disease, but a constellation of many different ones.

The summary below gives an overview of important additions and changes MPR has made to its drug database through the end of August. The chart below provides highlights of key monograph updates made this month (not an inclusive list).

This CME/CEU activity is designed to give clinicians a better understanding of the pharmacology, indications, contraindications, benefits/risk and clinical trials data of a broad spectrum of new agents and those that have been granted a new indication.